SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus: into single digits
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BigKNY3 who wrote (229)4/17/1998 4:46:00 PM
From: Mkilloran   of 1016
 
BigKNY3___________Approval of the new plant is still important IMO because the additional foreign countries that are approved do not all trail the MCA approval...there is still a need to have FDA approval of the new plant to supply these overseas markets. Short term this will help VVUS earnings while the US market share is being divided up between PFE Viagara and VVUS Muse...Time will tell if VVUS can hold 20% or more of the market...PFE is expanding the market to a much larger group that are now seeking DR's assistance.

NOW here's somthing to thing about ....when VVUS returns to double digets and stays there for 30 days...can we shut down the single diget board.... if VVUS stays under 10 for 30 days then this board
will be the main board....FOOD FOR THOUGHT....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News